Daniel Hancock Biography and Net Worth

Director of Cryoport

Daniel M. Hancock is Director of the Company. Mr. Hancock was appointed to Cryoport’s board of directors in January 2019 and serves as member of the Audit Committee and Scientific and Technology Committee. Mr. Hancock is currently President of DMH Strategic Consulting LLC. He retired from General Motors ("GM") in 2011, after 43 years of service in GM's powertrain engineering and general management functions. His last position with GM was Vice President, Global Strategic Product Alliances. During this period, he served as Chairman of GM's DMAX and VM Motori diesel engine joint ventures with Isuzu and Fiat, respectively. Mr. Hancock's previous appointments at GM included: Vice President, Global Powertrain Engineering; CEO, Fiat-GM Powertrain; and President, Allison Transmission Division. Mr. Hancock is a director of Westport Fuel Systems (NASDAQ WPRT), a Vancouver, B.C. based global supplier of clean gaseous fuel parts, and systems for the transportation industry. He is also serving as chairman of the board of SuperTurbo Technologies, Inc., a Loveland, CO based privately-held developer of advanced turbo compounding systems for engines and director of Achates Power, Inc., a San Diego, CA headquartered privately-held developer of innovative opposed-piston, two-stroke diesel engines. In addition, Mr. Hancock serves in an advisory capacity to several global suppliers to the automotive and commercial vehicle industries. He was President of SAE International in 2014 and is a member of the National Academy of Engineering. He received a master's degree in mechanical engineering from Massachusetts Institute of Technology (MIT) and a bachelor's degree also in mechanical engineering from General Motors Institute (now Kettering University), Michigan.

What is Daniel M. Hancock's net worth?

The estimated net worth of Daniel M. Hancock is at least $131,273.24 as of September 2nd, 2021. Mr. Hancock owns 5,201 shares of Cryoport stock worth more than $131,273 as of February 5th. This net worth estimate does not reflect any other assets that Mr. Hancock may own. Learn More about Daniel M. Hancock's net worth.

How do I contact Daniel M. Hancock?

The corporate mailing address for Mr. Hancock and other Cryoport executives is 112 Westwood Place Suite 350, Brentwood TN, 37027. Cryoport can also be reached via phone at (949) 470-2300 and via email at [email protected] Learn More on Daniel M. Hancock's contact information.

Has Daniel M. Hancock been buying or selling shares of Cryoport?

Daniel M. Hancock has not been actively trading shares of Cryoport during the last quarter. Learn More on Daniel M. Hancock's trading history.

Who are Cryoport's active insiders?

Cryoport's insider roster includes Richard Berman (Director), Daniel Hancock (Director), Mark Sawicki (Insider), Jerrell Shelton (CEO), Robert Stefanovich (CFO), and Edward Zecchini (Director). Learn More on Cryoport's active insiders.

Are insiders buying or selling shares of Cryoport?

During the last twelve months, insiders at the consumer goods maker sold shares 6 times. They sold a total of 17,761 shares worth more than $525,660.05. The most recent insider tranaction occured on December, 1st when Director Richard J Berman sold 7,250 shares worth more than $142,317.50. Insiders at Cryoport own 9.7% of the company. Learn More about insider trades at Cryoport.

Information on this page was last updated on 12/1/2022.

Daniel M. Hancock Insider Trading History at Cryoport

See Full Table

Daniel M. Hancock Buying and Selling Activity at Cryoport

This chart shows Daniel M. Hancock's buying and selling at Cryoport by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cryoport Company Overview

Cryoport logo
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Read More

Today's Range

Now: $25.24
Low: $24.98
High: $26.01

50 Day Range

MA: $19.49
Low: $15.97
High: $25.86

2 Week Range

Now: $25.24
Low: $15.63
High: $45.36


394,049 shs

Average Volume

469,868 shs

Market Capitalization

$1.24 billion

P/E Ratio


Dividend Yield